Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer

Xiaomei Qi, Congying Xie, Songwang Hou, Gang Li, Ning Yin, Lei Dong, Adrienne Lepp, Marla A. Chesnik, Shama P. Mirza, Aniko Szabo, Susan Tsai, Zainab Basir, Shixiu Wu, Guan Chen

Research output: Contribution to journalArticle

Abstract

A cancer phenotype is driven by several proteins and targeting a cluster of functionally interdependent molecules should be more effective for therapeutic intervention. This is specifically important for Ras-dependent cancer, as mutated (MT) Ras is non-druggable and targeting its interaction with effectors may be essential for therapeutic intervention. Here, we report that a protein-complex activated by the Ras effector p38γ MAPK is a novel therapeutic target for K-Ras-dependent colon cancer. Unbiased proteomic screening and immune-precipitation analyses identified p38γ interaction with heat shock protein 90 (Hsp90) and K-Ras in K-Ras MT, but not wild-type (WT), colon cancer cells, indicating a role of this complex in Ras-dependent growth. Further experiments showed that this complex requires p38γ and Hsp90 activity to maintain MT, but not WT, K-Ras protein expression. Additional studies demonstrated that this complex is activated by p38γ-induced Hsp90 phosphorylation at S595, which is important for MT K-Ras stability and for K-Ras dependent growth. Of most important, pharmacologically inhibition of Hsp90 or p38γ activity disrupts the complex, decreases K-Ras expression, and selectively inhibits the growth of K-Ras MT colon cancer in vitro and in vivo. These results demonstrated that the p38γ-activated ternary complex is a novel therapeutic target for K-Ras-dependent colon cancer.

Original languageEnglish (US)
Pages (from-to)4269-4282
Number of pages14
JournalOncotarget
Volume5
Issue number12
StatePublished - 2014
Externally publishedYes

Fingerprint

Ternary Complex Factors
HSP90 Heat-Shock Proteins
Colonic Neoplasms
Growth
ras Proteins
p38 Mitogen-Activated Protein Kinases
Protein Transport
Therapeutics
Immunoprecipitation
Proteomics
Neoplasms
Phosphorylation
Phenotype
Proteins

Keywords

  • Colon cancer
  • Hsp90
  • K-Ras
  • p38γ MAPK
  • Ternary complex
  • Therapeutic target

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Qi, X., Xie, C., Hou, S., Li, G., Yin, N., Dong, L., ... Chen, G. (2014). Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer. Oncotarget, 5(12), 4269-4282.

Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer. / Qi, Xiaomei; Xie, Congying; Hou, Songwang; Li, Gang; Yin, Ning; Dong, Lei; Lepp, Adrienne; Chesnik, Marla A.; Mirza, Shama P.; Szabo, Aniko; Tsai, Susan; Basir, Zainab; Wu, Shixiu; Chen, Guan.

In: Oncotarget, Vol. 5, No. 12, 2014, p. 4269-4282.

Research output: Contribution to journalArticle

Qi, X, Xie, C, Hou, S, Li, G, Yin, N, Dong, L, Lepp, A, Chesnik, MA, Mirza, SP, Szabo, A, Tsai, S, Basir, Z, Wu, S & Chen, G 2014, 'Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer', Oncotarget, vol. 5, no. 12, pp. 4269-4282.
Qi, Xiaomei ; Xie, Congying ; Hou, Songwang ; Li, Gang ; Yin, Ning ; Dong, Lei ; Lepp, Adrienne ; Chesnik, Marla A. ; Mirza, Shama P. ; Szabo, Aniko ; Tsai, Susan ; Basir, Zainab ; Wu, Shixiu ; Chen, Guan. / Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer. In: Oncotarget. 2014 ; Vol. 5, No. 12. pp. 4269-4282.
@article{546373b6b8484ccfa2a9076ee3215464,
title = "Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer",
abstract = "A cancer phenotype is driven by several proteins and targeting a cluster of functionally interdependent molecules should be more effective for therapeutic intervention. This is specifically important for Ras-dependent cancer, as mutated (MT) Ras is non-druggable and targeting its interaction with effectors may be essential for therapeutic intervention. Here, we report that a protein-complex activated by the Ras effector p38γ MAPK is a novel therapeutic target for K-Ras-dependent colon cancer. Unbiased proteomic screening and immune-precipitation analyses identified p38γ interaction with heat shock protein 90 (Hsp90) and K-Ras in K-Ras MT, but not wild-type (WT), colon cancer cells, indicating a role of this complex in Ras-dependent growth. Further experiments showed that this complex requires p38γ and Hsp90 activity to maintain MT, but not WT, K-Ras protein expression. Additional studies demonstrated that this complex is activated by p38γ-induced Hsp90 phosphorylation at S595, which is important for MT K-Ras stability and for K-Ras dependent growth. Of most important, pharmacologically inhibition of Hsp90 or p38γ activity disrupts the complex, decreases K-Ras expression, and selectively inhibits the growth of K-Ras MT colon cancer in vitro and in vivo. These results demonstrated that the p38γ-activated ternary complex is a novel therapeutic target for K-Ras-dependent colon cancer.",
keywords = "Colon cancer, Hsp90, K-Ras, p38γ MAPK, Ternary complex, Therapeutic target",
author = "Xiaomei Qi and Congying Xie and Songwang Hou and Gang Li and Ning Yin and Lei Dong and Adrienne Lepp and Chesnik, {Marla A.} and Mirza, {Shama P.} and Aniko Szabo and Susan Tsai and Zainab Basir and Shixiu Wu and Guan Chen",
year = "2014",
language = "English (US)",
volume = "5",
pages = "4269--4282",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "12",

}

TY - JOUR

T1 - Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer

AU - Qi, Xiaomei

AU - Xie, Congying

AU - Hou, Songwang

AU - Li, Gang

AU - Yin, Ning

AU - Dong, Lei

AU - Lepp, Adrienne

AU - Chesnik, Marla A.

AU - Mirza, Shama P.

AU - Szabo, Aniko

AU - Tsai, Susan

AU - Basir, Zainab

AU - Wu, Shixiu

AU - Chen, Guan

PY - 2014

Y1 - 2014

N2 - A cancer phenotype is driven by several proteins and targeting a cluster of functionally interdependent molecules should be more effective for therapeutic intervention. This is specifically important for Ras-dependent cancer, as mutated (MT) Ras is non-druggable and targeting its interaction with effectors may be essential for therapeutic intervention. Here, we report that a protein-complex activated by the Ras effector p38γ MAPK is a novel therapeutic target for K-Ras-dependent colon cancer. Unbiased proteomic screening and immune-precipitation analyses identified p38γ interaction with heat shock protein 90 (Hsp90) and K-Ras in K-Ras MT, but not wild-type (WT), colon cancer cells, indicating a role of this complex in Ras-dependent growth. Further experiments showed that this complex requires p38γ and Hsp90 activity to maintain MT, but not WT, K-Ras protein expression. Additional studies demonstrated that this complex is activated by p38γ-induced Hsp90 phosphorylation at S595, which is important for MT K-Ras stability and for K-Ras dependent growth. Of most important, pharmacologically inhibition of Hsp90 or p38γ activity disrupts the complex, decreases K-Ras expression, and selectively inhibits the growth of K-Ras MT colon cancer in vitro and in vivo. These results demonstrated that the p38γ-activated ternary complex is a novel therapeutic target for K-Ras-dependent colon cancer.

AB - A cancer phenotype is driven by several proteins and targeting a cluster of functionally interdependent molecules should be more effective for therapeutic intervention. This is specifically important for Ras-dependent cancer, as mutated (MT) Ras is non-druggable and targeting its interaction with effectors may be essential for therapeutic intervention. Here, we report that a protein-complex activated by the Ras effector p38γ MAPK is a novel therapeutic target for K-Ras-dependent colon cancer. Unbiased proteomic screening and immune-precipitation analyses identified p38γ interaction with heat shock protein 90 (Hsp90) and K-Ras in K-Ras MT, but not wild-type (WT), colon cancer cells, indicating a role of this complex in Ras-dependent growth. Further experiments showed that this complex requires p38γ and Hsp90 activity to maintain MT, but not WT, K-Ras protein expression. Additional studies demonstrated that this complex is activated by p38γ-induced Hsp90 phosphorylation at S595, which is important for MT K-Ras stability and for K-Ras dependent growth. Of most important, pharmacologically inhibition of Hsp90 or p38γ activity disrupts the complex, decreases K-Ras expression, and selectively inhibits the growth of K-Ras MT colon cancer in vitro and in vivo. These results demonstrated that the p38γ-activated ternary complex is a novel therapeutic target for K-Ras-dependent colon cancer.

KW - Colon cancer

KW - Hsp90

KW - K-Ras

KW - p38γ MAPK

KW - Ternary complex

KW - Therapeutic target

UR - http://www.scopus.com/inward/record.url?scp=84905098265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905098265&partnerID=8YFLogxK

M3 - Article

C2 - 24962213

AN - SCOPUS:84905098265

VL - 5

SP - 4269

EP - 4282

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 12

ER -